DIM
BEAM icon

DLK Investment Management’s Beam Therapeutics BEAM Stock Holding History

DLK Investment Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,125
Closed -$225K – 93
2025
Q4 		$225K Buy
+8,125
New +$207K 0.08% 74
2024
Q2 		– Sell
-7,225
Closed -$239K – 112
2024
Q1 		$239K Buy
+7,225
New +$225K 0.1% 73

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DLK Investment Management's BEAM Position: Q1 2026 in Review

DLK Investment Management sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 8,125 shares — an estimated $225K sold.

DLK Investment Management first reported a position in BEAM in Q1 2024 and held it in 2 quarters. The position peaked at $239K in Q1 2024. 252 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • DLK Investment Management reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
  • DLK Investment Management sold 8,125 Beam Therapeutics shares in Q1 2026, an estimated $225K.
  • DLK Investment Management first reported a position in Beam Therapeutics in Q1 2024 and held it in 2 quarters.
  • DLK Investment Management's Beam Therapeutics position peaked at $239K in Q1 2024.
  • 252 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on DLK Investment Management's 13F filing for Q1 2026, filed 15 Apr 2026.